KRAS and cancer: Notably, ARS-853 is a potent G12C allele-specific inhibitor that reduces cancer cell proliferation in vitro; its mechanism exploits the need of KRAS G12C nucleotide exchange to switch in the activated status, trapping it in the GDP-RAS state (58, 70).